Showing results (131-140 of 279) with videos related to
Sort By:
Pageof 28
Cancer|January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinomaLisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.Journal of Lipid Research|November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancerJonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.Cancer|December 19, 2007
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxelRobert W Ross, Tomasz M Beer, Susanna Jacobus, et al.The Journal of Urology|July 12, 2005
Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes StudyRobert A Stephenson, Motomi Mori, Yi-Ching Hsieh, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|March 29, 2016
Enzalutamide in Japanese patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer: A post-hoc analysis of the placebo-controlled PREVAIL trialGo Kimura, Junji Yonese, Takashi Fukagai, et al.Cancer|February 10, 2010
Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancerMark Garzotto, Celestia S Higano, Catherine O'Brien, et al.Anti-Cancer Drugs|September 27, 2016
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlatesColin P Bergstrom, Brian Ruffell, Christine M T Ho, et al.The Journal of Urology|January 13, 2006
Testosterone loss and estradiol administration modify memory in menTomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 6, 2021
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?Kerri M Winters-Stone, Cassie Boisvert, Fuzhong Li, et al.JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.Pageof 28